Clinical Trials Browser

Not yet recruiting × Nasopharyngeal Carcinoma × anlotinib × Clear all

NCT07540390 2026-04-22

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT07320963 2026-03-20

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Phase 1/2 Not yet recruiting

Nasopharyngeal Carcinoma